Runners and riders in the Covid vaccine race

Pfizer, AstraZeneca and Moderna have received approval for their Covid vaccines from the United kingdom regulator and the jabs are presently remaining rolled out. But what about the other vaccine candidates and how soon will they appear to market place?

Our list gives a snapshot of what the vaccine landscape seems to be like.

The life sciences industry’s response to the pandemic has been unprecedented both equally in terms of the velocity at which it has produced vaccines and its willingness to collaborate with rivals. That has resulted in 237 potential vaccines, of which 64 are in human clinical trials.

That is fantastic information as, in the vaccines business there is frequently no “a single-sizing-suits-all” solution, with distinctive countries requiring distinctive types of vaccines based on a variety of variables together with weather, land mass and demography. In other words and phrases: there is lots of home in the market place for much more than a single vaccine.

Covid vaccines accepted by the United kingdom

Pfizer/BioNtech

United kingdom approval date: December 2, 2020

Doses: 2

Efficacy: 90pc +

Kind: mRNA

Doses marketed or pre-ordered globally: The total sum is undisclosed, but we know it has 300m on get from the EU and 200m from the US, which, alongside one another with the United kingdom, provides the total to 540m

Doses procured by the United kingdom: 40m

Production ability: Up to 2bn doses this calendar year